Literature DB >> 23877360

Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway.

Libin Wang1, Qilun Liu, Fang Li, Jing Qiu, Heng Fan, Haibin Ma, Yongzhao Zhu, Ligang Wu, Xuebo Han, Zhihong Yang, Haifeng Jiang, Jun Wei, Haibin Xia.   

Abstract

The peroxisome proliferator-activated receptor-γ (PPAR-γ) coactivator-1β (PGC-1β) is a well-established regulator of mitochondrial biogenesis. However, the underlying mechanism of PGC-1β action remains elusive. This study reveals that knockdown of endogenous PGC-1β by short-hairpin RNA (shRNA) leads to a decrease in the expression of mammalian target of rapamycin (mTOR) pathway-related genes in MDA-MB-231 cells. After knockdown of PGC-1β, phosphorylation of AMP-activated protein kinase (AMPK), phosphorylation of Rictor on Thr1135, Raptor and S6 protein was inhibited. However, Akt phosphorylation on Ser473 was upregulated and cell apoptosis occurred. In particular, we demonstrate that the levels of PGC-1β and mTOR correlated with overall mitochondrial activity. These results provide new evidence that cell apoptosis is orchestrated by the balance between several signaling pathways, and that PGC-1β takes part in these events in breast cancer cells mediated by the mTOR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23877360     DOI: 10.3892/or.2013.2628

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Downregulated hypoxia-inducible factor 1α improves myoblast differentiation under hypoxic condition in mouse genioglossus.

Authors:  Yun Lu; Jiaqi Mao; Xinxin Han; Weihua Zhang; Yuanyuan Li; Yuehua Liu; Qiang Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

2.  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.

Authors:  Kurt W Fisher; Binita Das; Hyun Seok Kim; Beth K Clymer; Drew Gehring; Deandra R Smith; Diane L Costanzo-Garvey; Mario R Fernandez; Michael G Brattain; David L Kelly; John MacMillan; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

Review 3.  Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

Authors:  Yong Weon Yi; Kyu Sic You; Jeong-Soo Park; Seok-Geun Lee; Yeon-Sun Seong
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

4.  microRNA-378 promotes autophagy and inhibits apoptosis in skeletal muscle.

Authors:  Yan Li; Jingjing Jiang; Wei Liu; Hui Wang; Lei Zhao; Shengnan Liu; Peng Li; Shengjie Zhang; Chao Sun; Yuting Wu; Shuxian Yu; Xihua Li; Hui Zhang; Haifeng Qian; Duo Zhang; Feifan Guo; Qiwei Zhai; Qiurong Ding; Li Wang; Hao Ying
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

5.  UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma.

Authors:  Junjie Xu; Lin Ji; Yeling Ruan; Zhe Wan; Zhongjie Lin; Shunjie Xia; Liye Tao; Junhao Zheng; Liuxin Cai; Yifan Wang; Xiao Liang; Xiujun Cai
Journal:  Signal Transduct Target Ther       Date:  2021-05-18

6.  PGC-1β cooperating with FOXA2 inhibits proliferation and migration of breast cancer cells.

Authors:  Jia Cao; Xi Wang; Shihai Liu; Libin Wang; Danni Wang; Rong Ma; Xiaohan Li; Huimin Feng; Jia Wang
Journal:  Cancer Cell Int       Date:  2019-04-11       Impact factor: 5.722

Review 7.  mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer.

Authors:  Karen Griselda de la Cruz López; Mariel Esperanza Toledo Guzmán; Elizabeth Ortiz Sánchez; Alejandro García Carrancá
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

8.  Evolution of β-catenin-independent Wnt-GSK3-mTOR signalling in regulation of energy metabolism in isoproterenol-induced cardiotoxicity model.

Authors:  Shriyansh Srivastava; Newly Bagang; Shubham Yadav; Sakshi Rajput; Divya Sharma; Ashish Dahiya; Loveinder Bhardwaj; Khalid Deshmukh; Jagdish Chandra Joshi; Gaaminepreet Singh
Journal:  Inflamm Res       Date:  2021-06-29       Impact factor: 4.575

9.  Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways.

Authors:  Xiao Li Yang; Feng Juan Lin; Ya Jie Guo; Zhi Min Shao; Zhou Luo Ou
Journal:  Onco Targets Ther       Date:  2014-06-13       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.